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Abstract
Introduction: Chronic low-grade inflammation is associated with obesity and
diabetes. However, what causes and mediates chronic inflammation in metabolic
disorders is not well understood. Toll-like receptor 4 (TLR4) mediates both
infection-induced and sterile inflammation by recognizing pathogen-associated
molecular patterns andendogenousmolecules, respectively. Saturated fatty acids can
activate TLR4, and TLR4-deficient mice were protected from high fat diet (HFD)-
induced obesity and insulin resistance, suggesting that TLR4-mediated inflamma-
tion may cause metabolic dysfunction, such as obesity and insulin resistance.
Methods: We generated two transgenic (TG) mouse lines expressing a
constitutively active TLR4 in adipose tissue and determined whether these TG
mice would show increased insulin resistance.
Results: TG mice fed a high fat or a normal chow diet did not exhibit increased
insulin resistance compared to their wild-type controls despite increased localized
inflammation in white adipose tissue. Furthermore, females of one TG line fed a
normal chow diet had improved insulin sensitivity with reduction in both
adiposity and body weight when compared with wild-type littermates. There were
significant differences between female and male mice in metabolic biomarkers and
mRNA expression in proinflammatory genes and negative regulators of TLR4
signaling, regardless of genotype and diet.
Conclusions: Together, these results suggest that constitutively active TLR4-
induced inflammation in white adipose tissue is not sufficient to induce systemic
insulin resistance, and that high fat diet-induced insulin resistance may require
other signals in addition to TLR4-mediated inflammation.
Introduction
Toll-like receptors (TLRs) can induce innate immune
responses by recognizing invariant pathogen-associated
molecular patterns, leading to activation of downstream
signaling pathways and the expression of diverse arrays of
proinflammatory marker gene products that are required for
host defense against invading pathogens. In addition, TLRs
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can be activated by endogenous molecules derived from
tissue injury or stress and saturated fatty acids (SFAs) to elicit
sterile inflammation [1–5]. Results from genetic, clinical,
and biochemical studies suggest that TLR-mediated inflam-
mation is an important determinant in modifying the risk of
the development of many chronic diseases, including
diabetes and cardiovascular disease [6].
Our previous studies revealed that SFAs can activate
TLR4-, TLR2-, and NODs-mediated signaling pathways in
vitro [1, 2, 4, 5, 7]. Activation of TLRs orNODs by SFAs can
induce activation of downstream signaling molecules,
including IKKb and JNK, leading to impairment of insulin
signaling pathways. Such effects mechanistically link TLR-
induced inflammation to insulin resistance (IR) in
adipocytes and muscle cells [8–14]. In addition, TLR
pathway induced cytokines, such as TNF-a and IL-6, are
also known to impair insulin signaling [15, 16]. TLR4-
mediated ceramide production can suppress glucose
uptake and interfere with the insulin signaling path-
way [17]. Furthermore, the effects of SFA-induced TLR4
activation on IR has been studied using TLR4 knockout
(KO) mice or TLR4 loss-of-function mutant mice. Knock-
out or loss-of-function of TLR4 or TLR2 and TLR4 double
KO mice are protected from high fat diet (HFD)-induced
inflammation and IR in white adipose tissue
(WAT) [18–20]. TLR2 KO mice also showed reduced
WAT inflammation, and greater insulin-stimulated glu-
cose uptake inWAT stromal vascular cells compared to the
wild-type (WT) controls [21]. In addition, administration
of the TLR4 ligand LPS induces inflammation and IR in
mice and humans [22–25]. TLR4 is ubiquitously expressed
and thus, endogenously expressed TLR4 cannot be
activated in an organ-specific manner by LPS. Since
saturated fatty acids or LPS can activate multiple signaling
pathways, specific activation of TLR4 in a ligand indepen-
dent manner would be a more appropriate experimental
model to determine whether TLR4-mediated inflamma-
tion is sufficient to induce metabolic dysfunction.
Therefore, we generated transgenic mice ectopically
expressing a constitutively active TLR4 driven by aP2
promoter and evaluated metabolic changes in the
transgenic mice compared to their littermate controls
under a HFD and a normal chow diet (NCD).
We found that constitutive activation of TLR4 signaling
pathway in adipose tissues was not sufficient to impair insulin
sensitivity, regardless of diet. Rather, females of one line of TG
mice fed a NCD exhibited improved insulin sensitivity and
decreased adiposity. These results suggest that enhanced
TLR4-mediated inflammation in adipose tissue alone does
not lead to impairment of systemic insulin sensitivity inmice,
and that TLR4-mediated inflammation may be necessary but
not sufficient to induce the development of IR.
Results
DTLR4 transgene under aP2 promoter is specifically
expressed in adipose tissue and bone marrow
derived macrophages (BMDM)
Two TG founder mice that express DTLR4 transgene were
generated (P7 and F26 line). Schematic designs of the
transgene under aP2 promoter (aP2-DTLR4) were depicted
in Figure 1. HA-tagged DTLR4 protein was detected in
various WAT depots (PG, RP, and SQ), BAT, and peritoneal
macrophages (Fig. 2A and B). As expected, DTLR4 protein
was not detected in the liver, gastrocnemius, small intestine,
or brain and only small amount detected in cardiac muscle.
Moreover, transgene mRNA was detected in BMDM of the
P7 line (Fig. 2C). The transgene expression profile is
consistent with reported endogenous aP2 expression in
adipocytes [26], macrophages [26], and cardiomyo-
cytes [27]. When the transgene expression levels are
compared, line F26 had an expression level that is around
fivefold higher than that of line P7 (Fig. 2D). Therefore, we
have chosen to focus on the P7 line, which may mimic the
low-grade inflammation seen in obesity. All data presented
Figure 1. Generation of the HA-DTLR4 construct. Constitutively active TLR4 (DTLR4) was generated by deleting leucine-rich repeats in the N-terminus
from the full length TLR4 (A). DTLR4 was tagged with the hemagglutinin (HA) tag and was ligated downstream of aP2 promoter followed by a
polyadenylation signal sequence of bovine growth hormone to generate aP2-DTLR4, as shown in (B).
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are from the P7 line unless otherwise indicated. Data from
line F26 are provided in the Supplemental Figures.
Constitutive activation of TLR4 under aP2
promoter decreases food intake, total body and
fat pad weights, and muscle weight in female
mice fed a NCD, but not a HFD
To study the effects of constitutively active TLR4 in adipose
tissue on the development of obesity, inflammation and
insulin resistance, transgenic mice, and their wild-type
littermate controls were put on either a normal chow diet
(NCD) or a high fat diet (HFD). On the NCD diet, P7 female
TG mice had a decrease in body weight starting at 4 weeks
compared to their WT littermates (Fig. 3A). At termination
(25 weeks of age), P7 female TG mice had gained 21% less
weight than their WT littermates (time genotype, p< 0.01
with ANOVA with repeated measures). When fed the HFD,
P7 female mice also had less body weight, but the difference
did not reach statistical significance (time genotype,
p¼ 0.127 with ANOVA with repeated measures, Fig. 3B).
P7 male mice fed the NCD or the HFD did not show
significant differences in body weights (time genotype,
p¼ 0.941 and p¼ 0.987, respectively, ANOVA with repeated
measures) (Fig. 3A and B). Furthermore, P7 female TGmice
fed the NCD consumed less food than their WT littermates
(WT: 3.32 0.117, TG: 3.01 0.054 g/day) (p< 0.01), as
measured from 17th week on the diet to the end of the study.
However, the food intake of P7 male mice was not different
from that of the WT littermates during this period (WT:
3.48 0.10, TG: 3.45 0.11 g/day). P7 female and male TG
mice fed the HFD showed no significant difference in food
intake either (data not shown).
In agreement with body weight data, total adipose tissue
weight (sumof collectedWATandBATdepots) ofP7 femaleTG
mice fed theNCDwas smaller compared to theirWT littermates.
P7 female TG perigondal (PG) and subcutaneous (SQ) fat pads
weighed significantly less than their WT littermates. P7 female
TG retroperitoneal (RP) fat pads tended to weigh less than their
WT littermates, but did not reach statistical significance
(p¼ 0.057, Fig. 3C). In addition to decreases in adipose tissue
masses, the gastrocnemius of P7 female TG mice weighed
significantly less than their WT littermates (WT:
0.2246 0.005g, TG: 0.2096 0.002 g; p< 0.05) (Fig. 3E).
Neither P7 male TG mice fed the NCD or the HFD showed
significant differences in the masses of either adipose depots
(Fig. 3C and D) or gastrocnemius (Fig. 3E and G) when
compared to their same sex littermates. Additionally, P7 female
andmaleWTandTG liversweighed the same compared to their
same sex littermates, regardless of the diet (Fig. 3F and H).
Body weights and fat tissue weights on either NCD or
HFD were also measured in the second line of transgenic
mice, line F26. There were no differences in body weight gain
between the TG and WT littermates in both sexes when the
Figure 2. Expression of HA-DTLR4 in fat pads and macrophages in the transgenic mice. (A and B) Protein expression of HA-DTLR4 in various fat pads,
tissues, or peritoneal macrophages from two lines were analyzed by immunoprecipitation. (C) mRNA expression of HA-DTLR4 in the BMDM of line P7.
(D) Line F26 has higher HA-DTLR4 mRNA expression than that of the P7 line in perigonadal (PG) fat. Data¼Mean SEM (n¼ 5). The experiments have
been performed more than three times. The representative results are shown. Two tailed Student's t-tests were conducted (WT vs. TG). p< 0.05;
p< 0.01; p< 0.001. BF, brown fat; BMDM, bone marrow derived macrophages; Gas, gastrocnemius; HT, heart; Liv, liver; NC, negative control
HEK293T cell lysate; PC, positive control (cell lysate of HEK293T cells transfected with HA-DTLR4 expression plasmid); RP, retroperitoneal fat; SI, small
intestine; SQ, subcutaneous fat; TG, transgenic mice; WT, wild-type mice.
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mice were fed aHFD (Supplemental Fig. S1B) or between the
female TG and WT mice when fed a NCD (Supplemental
Fig. S1A). At termination, there were no differences in the fat
pad weights in the female mice fed the NCD (Supplemental
Fig. S1C) or males and females fed the HFD (Supplemental
Fig. S1D).
Constitutive activation of TLR4 under aP2 promoter
does not impair systemic insulin sensitivity
We examined the effects of transgene expression on insulin
and glucose sensitivities. P7 female TG mice fed the NCD
were more insulin sensitive than their WT littermates as
measured by insulin tolerance tests (ITT) (genotype
p< 0.05, ANOVA with repeated measures) (Fig. 4A). P7
male TGmice fed the NCD showed no significant differences
in insulin sensitivity compared with their WT littermates
(Fig. 4A). Under the NCD, male mice showed poor insulin
sensitivity compared to their female counterparts fed the
NCD (2-way ANOVA, p< 0.05, sex, p< 0.001, no interac-
tion) (Fig. 4A). Under the HFD, there were no differences in
insulin sensitivities between the TG and WT mice of both
sexes and male mice showed poor insulin sensitivity
compared to their female counterparts (2-way ANOVA;
Figure 3. Body weight over time and terminal fat pad weights in TG mice compared with the WT littermate controls. (A and B) male (M) and female (F)
TG and their WT littermate controls were fed either a NCD or HFD from 5 weeks of age and body weights recorded over 20 weeks on diet. The data
were analyzed by ANOVA with repeated measures of genotype time. ##p< 0.01. (C and D) Tissue weights of various fat pads were measured at
termination. RP and BF data are on separate graphs to better display the differences. (E–H) Gastrocnemius (gas) and liver weights frommice on the NCD
(E and F) or HFD (G and H) were weighed. BF, brown fat; Gas, gastrocnemius; PG, perigonadal fat; RP, retroperitoneal fat; SQ, subcutaneous fat; TA, sum
of total adipose. Data¼Mean SEM (n¼ 7–27). A few error bars are hidden by the symbols. Two tailed Student's t-tests were conducted (WT vs. TG).
p< 0.05; p< 0.01; p< 0.001.
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time, p< 0.001; sex, p< 0.001; no interaction) (Fig. 4B). On
the other hand, WT and TG mice of both sexes showed no
significant differences in glucose tolerance as measured by
glucose tolerance tests (GTT), regardless of the diets
(Fig. 4C and D). Consistently, male mice showed poor
glucose tolerance than their female counterparts (2-way
ANOVA, time, p< 0.001, sex, p< 0.001, no interaction). We
also examined the GTT and ITT in the female TGmice of line
F26 fed with the NCD. No significant differences were noted
in either test in the female TGmice compared with their WT
littermate controls (Supplemental Fig. S2).
P7 TG mice of both sexes also showed no significant
differences in fasting glucose or insulin compared to their
WT littermates after 20 weeks on their respective diets,
regardless of the diets (Table 1). High fat diet significantly
increased fasting glucose levels in both female and male
mice, regardless of the genotype (p< 0.001) (Supplemental
Fig. S3 A and B). Comparing female versus male mice, male
mice had higher levels of fasting blood glucose levels than
their female counterparts fed with either the NCD or HFD
(p< 0.001). High fat diet significantly increased fasting
insulin levels in male mice, but not in female mice
(Supplemental Fig. S3 C and D). There were no differences
between TG andWT in the calculated HOMA-IR, regardless
of sex and diet (Table 1).
Constitutive activation of TLR4 under aP2
promoter increases mRNA expression of
proinflammatory genes in the white adipose
tissues
Localized WAT inflammation has been associated with IR
and the development of type 2 diabetes mellitus
(T2DM) [28]. The effects of DTLR4 expression on
inflammatory and metabolic markers, as well as genotype
confirmation, were assessed by semi-quantitative RT-PCR
from the PGWAT depot.When fed with the NCD, P7 female
TG mice showed a significant increase in TNFa and MCP-1
mRNA expression compared to WT mice (115% and 266%
increase, respectively; p< 0.05, Fig. 5A). The expression of
NOX4 and JNK showed modest but significant decreases
(19% and 19% decrease, respectively; p< 0.05, Fig. 5A).
There were no significant differences in the expression of
COX2 (p¼ 0.10), IP-10, IL-2, IL-6, and CD68. (Fig. 5A).
Similarly, P7 male TG mice fed the NCD also had increased
expression of MCP-1 (95.7% increase, p< 0.01). IL-2
expression was elevated but the difference did not reach
statistical significance (97.9% increase, p¼ 0.088) and no
significant changes in other proinflammatory genes were
noted (Fig. 5B). When comparing the differences between
female and male mice, male mice had significantly higher
levels of both TNF-a (Fig. 5E and G) and MCP-1 mRNA
(Fig. 5F and H) in PG WAT than female mice, regardless of
diet (p< 0.001). Both male and female TG mice had higher
levels of TNF-a and MCP-1 mRNA than their WT controls
only when fed the NCD (Fig. 5E and F) (p< 0.05). However,
the percentages of induction were greater in the female TG
mice than in themale TGmice, although the differences were
not significant (Fig. 5A, B, E, and F).
Of note, female TG mice of line F26 also had increases in
TNFa and MCP-1 mRNA in the PG WAT compared with
their WT controls when fed the NCD (Supplemental Fig.
S4A).
When fed the HFD, P7 female TGmice showed significant
increases in the proinflammatory mediators IP-10 and IL-2,
compared to WT littermates (63% and 149% increase,
respectively; p< 0.05) (Fig. 5C). Similarly, P7 male TG mice
also increased IP-10 and IL-2 in PG WAT (106.3% and
58.4% increase, respectively; p< 0.05). There were no
significant changes in other proinflammatory genes noted
in either P7 female or male mice (Fig. 5C and D).
Plasma TNF-a, MCP-1, IL-6, and other adipokine levels
(total PAI-1, adipoq, leptin, and resistin like-a) were
measured. Plasma TNFa levels were undetectable in the
mice fed the NCD, but were not different between TG and
WT mice fed the HFD (Table 2). No significant differences
Figure 4. Female P7 TG mice fed the NCD were more insulin sensitive
than their WT littermate controls. (A and B) Insulin tolerance tests were
completed on TG mice compared to their WT controls in NCD and HFD,
respectively. (C and D) Glucose tolerance tests from TG mice and WT
controls fed NCD and HFD, respectively. Data¼Mean SEM (n¼ 7–27).
(A–D) ANOVA with repeated measures were used. #p< 0.05.
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were observed forMCP-1 levels among all samples (Table 2).
Plasma total PAI-1 levels were elevated in P7 female TGmice
fed the NCD but did not reach statistical significance
(p¼ 0.067). No differences were found in plasma IL-6,
adiponectin, leptin, and resistin-like-a between the TG and
WT mice, regardless of the diets and sex.
We further examined whether the expression of DTLR4
may affect the expression of TLR4 and other PRRs (TLR2,
NOD1, NOD2). DTLR4 expression did not significantly
affect endogenous TLR4 expression in the TG mice of
either sex fed with either diet (Fig. 6). DTLR4 expression
significantly decreased TLR2 expression in the P7 females
fed the NCD (23%, p< 0.05) (Fig. 6A). DTLR4 expression
significantly increased expression of NOD1 and NOD2
(31%, and 54% increase, respectively; p< 0.05) with no
significant effect on TLR2 expression (Fig. 6C) in the P7
females fed the HFD. There was no change in TLR2 mRNA
expression in the males fed either diet (Fig. 6B and D).
There were no changes in other PRR expression between
the female TG and WT mice of line F26 fed the NCD
(Supplemental Fig. S4B).
Constitutive activation of TLR4 under aP2 promoter
increases expression of negative regulators of TLR4
signaling in females of transgenic mice fed a HFD
Constitutive activation of TLR4 is known to desensitize the
response to the TLR4 agonist LPS in an organism [29]. The
constitutively active nature of DTLR4 in the TG mice may
produce suchdesensitization toTLR4 activationby increasing
expression of negative regulators of TLR4 signaling. Such
negative regulators of the TLR4 pathway include ATF3,
PPARg, A20, SOCS1, TOLLIP, SIGGIR, IRAKM, IL-RA, and
IL-10 [29–33]. We examined mRNA expression of these
negative regulators in thePGWATdepot ofmice fed theNCD
or HFD. P7 female TG mice fed the NCD exhibited a
significant increase of PPARgmRNA (50%, p< 0.05, Fig. 7A)
compared to their WT littermates. However, mRNA
expression of IL-RA and ATF3 was suppressed by 63%
(p< 0.05) and 27.5%, respectively (p< 0.01). No significant
differences were seen in the other negative regulators of the
TLR4 pathway measured (A20, SOCS1, TOLLIP, SIGGIR,
IRAKM). In contrast, P7 female TG mice fed the HFD had
significant increases in the mRNA expression of multiple
negative regulators of the TLR4 pathway, including A20,
SOCS1, TOLLIP, SIGIRR, and IRAKM, compared to those in
their WT littermates (32%, 62%, 30%, 38%, and 26%
increase, respectively; p< 0.05) (Fig. 7C). The expression of
the negative regulator ST2L was also increased (32%), but it
did not reach statistical significance (p¼ 0.053). In contrast,
ATF3 mRNA was significantly suppressed (37%, p< 0.05).
None of these negative regulators of TLR4 signaling were
changed in themale TGmice compared to theirWT controls,
regardless of the diet (Fig. 7B and D). When comparing the
differences between female and male mice, under the NCD
female TG mice had higher PPARg mRNA than female WT
mice.Male TGmice also had higher PPARgmRNA thanmale
WTmice (Fig. 7E). However, PPARg up-regulation in female
TGmice was higher thanmale TGmice (p< 0.01). Under the
HFD, female mice had higher PPARgmRNA than their male
counterparts (Fig. 7G). TG mice of both sexes had higher
PPARg mRNA than their same sex WT controls (Fig. 7G).
Regardless of diet, female mice had lower ATF3 mRNA than
their male counterparts (p< 0.001 for both diets). TG mice
had lower ATF3 mRNA than their WT controls, regardless of
sex (p< 0.05 for both diets).None of the negative regulators of
TLR4 signaling had altered expression levels in the female TG
mice of line F26 when fed the NCD (Supplemental Fig. S4C).
Discussion
Previous studies have shown SFAs can activate TLR4,
inducing sterile inflammation and IR [34]. The role of sterile
inflammation induced by a HFD (typically 60% kcal from
fat) in the development of IR has been investigated by using
murine KOmodels of proinflammatory genes (TLRs, NF-kB
subunits, cytokines, etc.). For instance, TLR4 or TLR2 KO
mice were partially protected from the HFD-induced
inflammation and IR [18, 19, 35, 36]. These mice tend to
be more insulin sensitive as measured by ITT or have
improved insulin signaling. The protection of TLR4 mutant
or KO mouse models from HFD-induced IR has been
Table 1. Plasma glucose and insulin levels and HOMA-IR of mice at termination after being fed a normal chow diet (NCD) or a high fat diet (HFD).
Female Male
WT  SEM TG  SEM p WT  SEM TG  SEM p
Glucose 20wk NCD 106.9 4.99 110.4 4.98 ns 142.3 6.54 145.3 5.46 ns
(mg/dL) HFD 139.5 9.2 145.5 5.38 ns 181.1 9.8 170.1 7.21 ns
Insulin 20wk NCD 0.55 0.07 0.83 0.11 ns 0.39 0.07 0.29 0.02 ns
(ng/mL) HFD 0.48 0.12 0.57 0.07 ns 0.87 0.17 0.79 0.09 ns
HOMA-IR 20wk NCD 3.67 0.6 4.87 0.59 ns 3.42 0.59 2.73 0.29 ns
HFD 4.09 0.98 5.09 0.67 ns 9.82 1.97 9.1 1.23 ns
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Figure 5. Femaleandmale TGmice showed increasedmRNAexpressionof select proinﬂammatory genes inperigonadal (PG)WAT fedeitherNCDorHFD.
(A–D) mRNA expression of proinﬂammatory gene in the PGWAT of the TGmice compared with their WT littermate controls was determined in mice fed
the NCD (A and B) or HFD (C and D). The data of female or male TGmice were presented as percentage relative to their same sexWT counterparts on the
same diet (set to be 100%). (E–G) TNF-a andMCP-1mRNA levelswere compared betweenmale and femalemice fed the NCD (E and F) or the HFD (G and
H). The datawere presented as percentage relative to the femaleWTmice on the samediet (set to be 100%). Datawere analyzed using theDelta Delta CT
and the relative abundance of transcripts were normalized to HPRT-1. Abbreviations are in Supplemental Table S1. Data¼Mean SEM (n¼ 7–27). (A–D)
Two tailed Student's t-tests were conducted (WT vs. TG). p< 0.05; p< 0.01; p< 0.001. (E–G) 2-way ANOVAs were conducted (sex, genotype, and
interaction). No interaction between sex and genotype was found. p< 0.05 for WT versus TG; p< 0.001 for female versus male.
Activation of TLR4 in adipose tissue dose not impair insulin sensitivity K. D. Ono-Moore et al.
532 © 2017 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd.
attributed to decreased inflammation particularly in
WAT [18, 19, 36] and suggests that HFD-induced IR is at
least in part mediated through TLR4 signaling pathways; this
raised another question: whether in vivo activation of TLR4
would be sufficient to induce IR? However, direct evidence
that TLR4 activation in WAT promotes development of IR
has not been demonstrated. Therefore, the purpose of this
study was to investigate whether the activation of TLR4 in
the adipose tissues in a ligand independent and adipose-
specific manner induces metabolic changes, such as obesity
and insulin resistance. Accordingly, we have generated the
transgenic mice expressing the constitutively active DTLR4
in adipose tissue under the control of the aP2 promoter
(aP2-DTLR4). Phenotypes of these transgenic mice may
reveal whether the specific ligand independent activation of
TLR4 in adipose tissue is sufficient to induce IR. One
limitation of using aP2 promoter to drive the transgene
expression in adipose tissue is that the transgene can be
expressed not only in adipose tissue but also in macrophages
that reside many tissues and organs. Thus, the interpretation
of the results presented here is made in recognition of this
limitation.
Based on the two transgenic lines that were generated and
characterized, we found that aP2-driven expression of
constitutively active TLR4 was not sufficient to induce
systemic insulin resistance, despite being sufficient to induce
elevated inflammation in WAT. Moreover, female, but not
male, mice of one line of transgenic mice exhibited
greater insulin sensitivity and decreased body weight when
fed a NCD. When fed with a HFD, female mice from this
line exhibited no difference in body weight and insulin
sensitivity compared toWT littermate controls, possibly due
to robust upregulation of negative regulators of TLR4
signaling, PPARg, A20, SOCS1, TOLLIP, SIGGIR, IRAKM,
and IL-10 [29–33], which may have dampened inflamma-
tion induced by the constitutive expression of DTLR4
under HFD.
It is well known that adiposity and body weight gain can
greatly influence insulin sensitivity [37, 38]. Therefore, the
improved insulin sensitivities may be associated with the
reduced body weight and adiposity found in the P7 female
TG mice fed the NCD. Reduced body weight and adiposity
may be due to increased energy expenditure and/or changes
in food intakes caused by DTLR4-mediated inflammation as
enhanced inflammation is known to cause a substantial
increase in energy expenditure [39]. This increase in energy
expenditure and metabolic rate is due to the induction of
fever and the activation of immune cells. It is noteworthy
that transgenic mice with over-expression of p65 (a subunit
of NFkB) [40] or IKKb [41] using the aP2 promoter
exhibited improved insulin sensitivity despite increased
inflammation. Tang et al. [40] reported that mice with aP2
promoter driven p65 expression or mice with a global KO of
p50 were protected from the diet-induced IR and impaired
glucose tolerance despite increased systemic inflammation
and increased localized WAT inflammation. Both adipose-
specific p65 and IKKb transgenic mice showed increased
metabolic rate, which might have contributed to the
improved insulin sensitivity [40, 41]. However, we did not
detect significant differences in energy expenditure in the TG
mice compared to the WT controls (Supplemental Fig. S5).
On the other hand, inflammation affects food intake. The
Table 2. Plasma adipokine levels of mice at termination after being fed a normal chow diet (NCD) or a high fat diet (HFD).
Female Male
WT SEM TG SEM p WT SEM TG SEM p
Adipq NCD 74.79 5.06 77.06 3.48 ns 60.32 4.06 60.51 3.05 ns
(mg/mL) HFD 16.72 1.06 18.84 0.89 ns 13.29 0.85 13.96 0.55 ns
PAI NCD 3.28 0.39 4.31 0.32 0.06 3.48 0.52 3.95 0.39 ns
(ng/mL) HFD 2.37 0.46 2.78 0.32 ns 2.26 0.59 3.05 0.36 ns
Leptin NCD 4.03 0.71 3.08 0.45 ns 5.17 1.23 6.05 0.95 ns
(ng/mL) HFD 15.83 4.06 13.54 2.23 ns 17.9 1.88 20.69 2.52 ns
Resistin NCD 1.77 0.15 1.63 0.05 ns 1.38 0.09 1.43 0.09 ns
(ng/mL) HFD 2.33 0.35 2.38 0.22 ns 2.26 0.34 2.38 0.17 ns
IL-6 NCD 8.19 0.8 6.83 0.39 0.11 7.00 0.36 6.78 0.39 ns
(pg/mL) HFD 14.19 3.34 12.83 1.77 ns 19.29 6.67 6.55 0.4 ns
MCP-1 NCD 5.24 2.15 5.61 1.00 ns 8.09 3.53 7.05 1.54 ns
(pg/mL) HFD 70.16 14.89 66.06 8.89 ns 71.03 11.31 61.31 8.95 ns
TNF NCD UD UD ns UD UD ns
(pg/mL) HFD 9.56 2.9 7.24 1.59 ns 5.46 2.45 1.32 0.33 ns
p-Values were calculated using the Student's t-test (two-tailed) from transformed data, when needed, between WT and TG groups by diet.
p-Value is calculated using a binary method because over 50% of the values were below the limit of detection. Values above the detectable limit were
given a value of 1 and values below the detectable limit were given a value of 0.
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cytokines, TNF-a and IL-1a, have been shown to suppress
food intake [42]. The decrease in body weight in P7 female
TG mice fed the NCD is associated with a reduction in the
food intake, which could have been caused by cytokines
induced by the transgene-induced inflammation. There was
increased TNF-amRNA in WAT in the P7 female TG mice;
however, whether this increase led to elevated circulating
levels of TNF-a has not been confirmed because plasma
TNF-a levels were not detectable in mice fed the NCD.
Together, our results and other studies with IKKb or p65
transgenic mice [40, 41] suggest an intriguing possibility that
inflammation in white adipose tissue may have indirect
effects in improving insulin sensitivity through reducing
food intake and/or body weight, which can counteract
impairment of insulin signaling caused by proinflammatory
signals.
It should be noted that although the activation of TLR4,
IKKb, or p65 all leads to increased expression of
proinflammatory gene products, IKKb or p65 are both
downstream components of TLR4. TLR4 can activate
multiple downstream signaling pathways (i.e., PI3K, NOX,
micro RNA anti-inflammatory pathways), which may not be
affected by the overexpression of further downstream
signaling components, such as IKKb or p65. Therefore,
divergent phenotypes of the DTLR4 transgenic mice with
IKKb or p65 transgenic mice [40, 41] are expected. All three
transgenic mice showed increased inflammation in adipose
tissues but with no impairment in insulin sensitivity,
suggesting that the contribution of decreased body weight
to improved insulin sensitivity found in those transgenic
animals might have overridden the impairment of insulin
signaling caused by increased inflammation in WAT.
The compensatory mechanism of the immune system to
TLR4 activation by LPS has been well documented. In vivo, a
second exposure to LPS (TLR4 ligand) exhibits a decreased
inflammatory response compared to the first exposure, a
phenomenon known as ‘‘endotoxin tolerance.’’ Not only
proinflammatory mediators but also negative regulators of
the TLR pathway (e.g., IRAKM and SIGIRR) are in part
responsible for endotoxin tolerance. Our transgenic mice
with the constitutive activation of TLR4 in adipose tissue
might have altered local and systemic inflammatory status
due to up regulation of the negative regulators of the TLR4
pathway as a result of transgene DTLR4 expression. This
hypothesis seems more apt to describe the up-regulation of
the negative regulators in the female TG mice fed the HFD
than female mice fed the NCD. Whether HFD alone in non-
transgenic mice can up-regulate the expression of the
negative regulators will need to be determined in the future.
While female TGmice fed the NCDhad increased expression
of PPARg, it is not known whether this or other negative
regulators of TLR4 are also up-regulated in IKKb and p65
transgenic mice. It is possible that the signaling pathways
leading to the expression of negative regulators might have
diverged from the upstream of IKKb.
As only female TG mice fed the NCD showed significant
differences in body weight, food intake, and insulin
sensitivity compared to their WT controls, we compared
sex differences in metabolic markers and mRNA expression
of proinflammatory genes and negative regulators of TLR4
signaling. Regardless of diet and genotype, male mice had
poor insulin sensitivity and glucose tolerance, higher
proinflammatory TNF-a and MCP-1 mRNA, and higher
ATF3 mRNA compared to their female counterparts. HFD-
fed female had higher PPARg than their male counterparts,
regardless of genotype and TG mice had higher PPARg
mRNA than the WT controls. NCD-fed female TG mice had
higher PPARg than male TG mice fed the NCD, but there
were no differences in PPARg mRNA between female and
male WT mice fed the NCD. HFD-fed male mice showed
both insulin resistant and glucose intolerant than male
Figure 6. Female TG mice showed decreased TLR2 mRNA fed the NCD,
but increased NOD1 and NOD2 mRNA when fed the HFD. mRNA
expression of endogenous TLR4 and other pattern recognition receptors
in the WAT of the TG mice compared with their littermate controls was
determined in mice fed the NCD (A and B) or the HFD (C and D). Data
were analyzed using the Delta Delta CT and the relative abundance of
transcripts were normalized to HPRT-1. The data of female or male TG
mice were presented as percentage relative to their same sex WT
counterpart (set to be 100%). Abbreviations are in Supplemental
Table S1. Data¼Mean SEM (n¼ 7–27). Two tailed Student's t-tests
were conducted (WT vs. TG). p< 0.05; p< 0.01; p< 0.001.
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Figure 7. Female TGmice fed the HFD showed increased mRNA expression of PPARg and other negative regulators of TLR4. (A–D) mRNA expression of
select negative regulators of TLR4 signaling in the PGWAT of TGmice compared with their WT littermate controls was determined in mice fed the NCD
(A and B) or HFD (C and D). The data of female or male TGmice were presented as percentage relative to their same sexWT counterpart on the same diet
(set to be 100%). (E–G) PPARg and ATF3 mRNA levels were compared between male and female mice fed the NCD (E and F) or the HFD (G and H). The
data were presented as percentage relative to the female WT mice on the same diet (set to be 100%). Data were analyzed using the Delta Delta CT and
the relative abundance of transcripts were normalized to HPRT-1. Abbreviations are in Supplemental Table S1. Data¼Mean SEM (n¼ 7–27). (A–D)
Two tailed Student's t-tests were conducted (WT vs. TG). p< 0.05; p< 0.01; p< 0.001. (E–G) Two-way ANOVAs were conducted (sex, genotype,
and interaction). (E) There was a signiﬁcant sex by genotype interaction for the expression of PPAR-g in mice fed a NCD (p< 0.05). Groups with differing
letters indicate a signiﬁcant difference (p< 0.05). (F–H) No interaction between sex and genotype for other variables was found. p< 0.05 forWT versus
TG. p< 0.001 for female versus male.
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mice fed the NCD whereas HFD-fed female mice were only
more glucose intolerant compared to the female mice fed
the NCD. Our findings of the sex differences in
metabolic markers in mice are consistent with previous
reports [43, 44]. It seems that higher levels of proinflamma-
tory gene expression are associated with poor metabolic
biomarkers observed in a sex-specificmanner. Future studies
are needed to explore the roles of negative regulator PPARg
and ATF3 in TLR4-mediated inflammation and associated
metabolic impact.
It is noted that only one of the two transgenic lines (line P7)
in our study showed reduced body weight and food intakes
with improved insulin sensitivities. The phenotypes of the
transgenicmice are known to be affected by the locationof the
insertion of the transgene. It is possible that differences in the
phenotypes of our two lines are affected by their insertion sites
in the genome.However, both lines of the transgenicmice did
not show impaired insulin resistance.
In summary, our results demonstrate that ectopic
expression of constitutively active TLR4 driven by aP2
promoter induces inflammation in white adipose tissue;
however, it does not induce systemic insulin resistance.
Interestingly, female transgenic mice fed the NCD showed
improved insulin sensitivity compared to their WT litter-
mate controls. It should be confirmed in the future whether
high-fat diet induced insulin resistance may require other
signaling pathways and whether TLR4-mediated inflamma-
tion in white adipose tissue may have beneficial effects in
improving insulin sensitivity, possibly through reducing
food intake and/or body weight, which can counteract
impairment of insulin signaling caused by proinflammatory
signals. Our results that adipose-specific TLR4-mediated
sterile inflammation does not impair insulin sensitivity and
may actually improve it, underscores that our understanding
of roles of TLR4-mediated inflammation on insulin
sensitivity is incomplete.
Materials and Methods
Construction of constitutively active TLR4 under
aP2 promoter expression plasmid
The Toll in Drosophila embryo lacking the extracellular
leucine-rich repeat domain produces a dominant gain-
of-functionmutant of the TOLL protein [45]. The dominant
gain-of-function mutants do not require the ligand for
activation. Likewise, we previously found that the deletion of
the leucine-rich repeats in the N-Terminus of the murine
TLR4 produced a similar gain-of-function or a constitutively
active form of TLR4, named DTLR4 [46], as shown in
Figure 1A. The aP2 promoter-driven DTLR4 construct was
generated by ligating the 5.4 kb aP2 promoter/enhancer,
kindly provided by Dr. Bruce Spiegelman (Dana-Farber
Cancer Institute, Boston, MA), with HA-DTLR4 fragment
and a sequence of bovine growth hormone polyadenylation
signal sequence. HA-DTLR4 fragment was prepared by
polymerase chain reaction (PCR) using pcDNA3.1-HA-
DTLR4 [46] as a template with a 50 primer sequence
including a SmalI site and a Kozak consensus sequence,
paired with a 30 primer sequence including a ScaII site. The
schematic design is depicted in Figure 1B. TG mice were
generated using pronuclear injection techniques into
B6D2F1 fertilized eggs (Mouse Biology Program, University
of California, Davis, CA). Two lines of mice were established,
referred to as P7 and F26.Mice were genotyped by analysis of
tail genomic DNA. All animal procedures were approved by
the University California, Davis’s Institutional Animal Care
and Use Committee.
Mice
Mice were maintained under 12-h light and dark cycles in a
specific pathogen free facility, and were fed either a NCD
(PicoLab 5053, Lab Diet, Brentwood, MO) or a HFD, 60%
kcal from fat (product #D12492, ResearchDiets, NJ). ANCD
was used as the control in many KOmice studies [18, 19, 40,
41, 47–50] andwas used insteadof a semi-purified low fat diet
to be consistent with these studies. Body weight was
measured weekly starting at 5 weeks of age until the mice
were 25 weeks of age. Food intake was measured between 21
and 25 weeks of age. Fasting glucose levels were measured by
OneTouch Ultra 2 glucometer (LifeScan, Milpitas, CA) after
the animals were fasted overnight (12–14 h). Fasting insulin
levels were measured using the Ultra Sensitive mouse insulin
ELISA (Crystal Chem, Inc., Downers Grove, IL). HOMA-IR
was calculated as HOMA-IR¼ Fasting insulin (mIU/L)
Fasting glucose (mg/dL)/405 [51].
At termination, fasted mice were anesthetized with
isoflurane before terminal blood was collected by retro-
orbital bleeds or cardiac punctures. The mice were
euthanized by cervical dislocation; perigonadal (PG),
retroperitoneal (RP), and subcutaneous (SQ) WAT, and
brown adipose tissue (BAT) were collected, in addition to
the liver and gastrocnemius muscle. Tissues were immedi-
ately snap frozen in liquid nitrogen.
Glucose tolerance tests and insulin tolerance tests
Glucose tolerance tests (GTTs) and insulin tolerance tests
(ITTs) were performed as previously described [49]. Briefly,
GTTs were performed at 16 weeks of age (1 g/kg of body
weight of dextrose) after an overnight fast on mice fed a
NCDor aHFD.Dextrose (Hospira, Inc., Lake Forest, IL) was
diluted in injection grade water and administered by oral
gavage (Solomon Scientific, San Antonio, TX). ITTs were
performed at 17 weeks of age, after a 5 h fast. Humulin R
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insulin (Eli Lilly and Co., Indianapolis, IN) was diluted in
0.9% saline (Phoenix Pharmaceutical, Inc., Burlingame, CA)
and administered by intraperitoneal injection at 0.75U/kg of
body weight and glucose values were measured as using
OneTouch Ultra 2 glucometer.
Measurement of adipokines
Plasma levels of leptin, monocyte chemotactic protein-1
(MCP-1), tumornecrosis factor-a (TNF-a), total plasminogen
activator inhibitor-1 (total PAI-1), resistin-likea, interleukin-6
(IL-6), and adiponectin were measured using Milliplex bead-
based immunoassays (Millipore, Billerica, MA).
Quantitative real-time PCR
Total RNA was isolated from various tissues using the
RiboPure RNA isolation kit (Life Technologies, Inc.,
Grand Island, NY) per manufacturer’s instructions. RNA
integrity was analyzed using an Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA). RNA concentra-
tion was determined using a NanoDrop Spectrophotome-
ter (Thermo Fisher Scientific, Waltham, MA) and cDNA
was synthesized from 1mg of total RNA using Superscript
III cDNA synthesis kit (Life Technologies, Inc.). Semi-
quantitative PCR was performed using an ABI prism
7900 PCR instrument with gene-specific Taqman gene
expression assays (Supplemental Table S1). The relative
abundance of transcripts were normalized to hypoxan-
thine-guanine phosphoribosyltransferase-1 (HPRT-1).
Data were analyzed using the Delta Delta CT method as
previously described [52].
Immunoprecipitation analysis
Tissues were homogenized in M-PER (Thermo Fisher
Scientific) with the protease inhibitor HALT (Thermo
Fisher Scientific). Protein lysates were centrifuged at
10,000g at 48C for 10min and 16,000g at 48C for 10min
to clear lipids. Protein concentrations of the samples were
determined with Bradford Plus Protein Assay reagent
(Thermo Fisher Scientific). Immunoprecipitations were
performed with 0.5–5mg of protein lysates using anti-HA
affinity matrix (Roche, Indianapolis, IN) overnight. The
anti-HA affinity matrix was washed three times (once with
M-PER and twice with PBS) before 2 sample loading
buffer was added. The samples were heated for 3min
at 1008C then subjected to electrophoresis on 10%
Tris-Glycine gels, and transferred to polyvinylidene
difluoride (PVDF) membranes (Bio-Rad Laboratories,
Hercules, CA). The membrane was blocked in 5% non-
fat dry milk in tris-buffered saline with 0.1% tween 20
(TBS-T) for 1 h. The membrane was incubated with anti-
HA (Cell Signaling, Danvers, MA) in 2.5% non-fat dry
milk overnight. HRP conjugated secondary antibodies
(Amersham, Pittsburgh, PA) were incubated for 1 h in
2.5% of non-fat dry milk. The band was visualized using
the chemiluminescent substrate ELC Plus (Amersham,
Pittsburgh, PA).
Bone marrow-derived macrophages
Bone marrow-derived macrophages (BMDM) were isolated
as described [53]. Mice were euthanized by CO2 asphyxia-
tion. Intact femurs were collected in sterile PBS. Femurs were
sterilized in 70% ethanol for 2min before the bone cavities
were flushed with cold PBS. The cells were filtered through a
50mM cell strainer and collected by centrifugation. The cells
were resuspended in DMEM F-12, 10% FBS, 15% L-929
conditioned medium (produced as described [53]), 1%
penicillin/streptomycin (Life Technologies, Inc.), and 10mg/
mL plasmocin (Invivogen, San Diego, CA). BMDM were
considered differentiated on day eight at which time total
RNA was collected.
Statistical analysis
Results are presented as mean SEM. For temporal
outcomes, such as body weight gain, GTTs and ITTs,
ANOVA with repeated measures (Proc Mixed) was
conducted to compare differences between genotypes.
Other outcomes such as gene expression and tissue masses
were analyzed using the Student’s t-test (two-tailed) (SAS,
Windows Release 9.2 [Cary, NC]). Two-way ANOVA was
conducted to identify the interaction among sex, genotype,
and diet using GraphPad Prism 7 (GraphPad Software,
Inc.). Appropriate transformations were made when basic
testing assumptions were violated (e.g., log variable).
Outlier testing was conducted using the ROUT method
(GraphPad Prism Version 6, La Jolla, CA). Values of
plasma cytokines that were undetectable were replaced
using the 2/3 of the assay’s limit of detection. Statistical
significance was determined as p< 0.05 and statistical
trends was defined as p< 0.10.
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Figure S1. Body weight gain over time and terminal fat pad
weights in a second line (F26) TG mice compared with their
littermate controls.
Figure S2. Insulin and glucose tolerance tests in the female
TG mice of F26 compared to their WT littermate controls
when fed a normal chow diet.
Figure S3. Diet-induced differences in fasting blood glucose
and insulin levels. Fasting blood glucose (A and B) and
insulin (C and D) were compared between female (A and C)
and male (B and D) mice based on the genotype.
Figure S4. mRNA expression of TLR4 gene products (A), other
pattern recognition receptors (PRR) (B), andnegative regulators
of TLR4 (C) in the female TG mice of F26 line compared with
their WT littermate controls when fed a normal chow diet.
Figure S5. Respiratory exchange ratio (RER) (A) and energy
expenditure (EE) (B) of female mice of F26 line fed a NCD
did not differ between genotypes at 24 week of age.
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